Extracellular Vesicles in Molecular Diagnostics: An Overview with a Focus on CNS Diseases

B. R. Hirshman, R. T. Kras, J. C. Akers, B. S. Carter, C. C. Chen

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Scopus citations

Abstract

All known cells continuously release nanoscale lipid membrane-enclosed packets. These packets, termed extracellular vesicles (EVs), bear the signature of their cells of origin. These vesicles can be detected in just about every type of biofluid tested, including blood, urine, and cerebrospinal fluid. The majority comes from normal cells, but disease cells also release them. There is a great interest in collecting and analyzing EVs in biofluids as diagnostics for a wide spectrum of central nervous system diseases. Here, we will review the state of central nervous system EV research in terms of molecular diagnostics and biomarkers.

Original languageEnglish (US)
Title of host publicationAdvances in Clinical Chemistry
EditorsGregory S. Makowski, Gregory S. Makowski
PublisherAcademic Press Inc.
Pages37-53
Number of pages17
ISBN (Print)9780128046876
DOIs
StatePublished - Jan 1 2016

Publication series

NameAdvances in Clinical Chemistry
Volume76
ISSN (Print)0065-2423

    Fingerprint

Keywords

  • Brain cancer
  • Exosome
  • Extracellular vesicle
  • Neurodegenerative diseases

Cite this

Hirshman, B. R., Kras, R. T., Akers, J. C., Carter, B. S., & Chen, C. C. (2016). Extracellular Vesicles in Molecular Diagnostics: An Overview with a Focus on CNS Diseases. In G. S. Makowski, & G. S. Makowski (Eds.), Advances in Clinical Chemistry (pp. 37-53). (Advances in Clinical Chemistry; Vol. 76). Academic Press Inc.. https://doi.org/10.1016/bs.acc.2016.05.005